Division of Nephrology and Hypertension, Mayo Clinic, 200 First St SW, Rochester, MN.
Department of Radiology, Mayo Clinic, Rochester, Minnesota.
Acad Radiol. 2019 Nov;26(11):1488-1494. doi: 10.1016/j.acra.2018.12.008. Epub 2019 Jan 14.
Multidetector computed tomography (MDCT) is useful for measuring in the research setting single-kidney perfusion and function using iodinated contrast time-attenuation curves. Obesity promotes deposition of intrarenal fat, which might decrease tissue attenuation and thereby interfere with quantification of renal function using MDCT. The purpose of this study was to test the hypothesis that background subtraction adequately accounts for intrarenal fat deposition in mildly obese human subjects during renal contrast enhanced dynamic CT.
We prospectively recruited seventeen human subjects stratified as lean or mildly obese based on body mass index below or over 30 kg/m, respectively. Renal perfusion was quantified from CT-derived indicator-dilution curves after background subtraction. Dual-energy MDCT images were postprocessed to generate iodine and virtual-noncontrast datasets, and the ratios between kidney/aorta CT numbers and iodine values calculated as surrogates of renal function.
Subcutaneous adipose tissue was increased in obese subjects. Virtual-noncontrast maps revealed in obese patients a decrease in basal cortical and medullary attenuation. Overall, basal attenuation inversely correlated with body mass index, in line with renal fat deposition. Contrarily, the kidney/aorta CT attenuation (after background subtraction) and kidney/aorta iodine ratios were similar between lean and obese subjects and correlated directly. These observations show that following background subtraction, the CT number reliably reflects basal tissue attenuation.
Therefore, our findings support our hypothesis that background subtraction enables reliable assessment of kidney function in mildly obese subjects using MDCT, despite decreased basal attenuation due to renal adiposity.
多排螺旋 CT(MDCT)可用于在研究环境中通过碘造影剂时间衰减曲线来测量单肾灌注和功能。肥胖会促进肾内脂肪沉积,这可能会降低组织衰减,从而影响 MDCT 对肾功能的定量评估。本研究旨在检验以下假说,即在接受肾增强动态 CT 检查的轻度肥胖患者中,背景减除技术可充分校正肾内脂肪沉积对肾实质衰减的影响。
我们前瞻性地招募了 17 名患者,根据 BMI(体质量指数)分为消瘦组(BMI<30kg/m²)和轻度肥胖组(BMI≥30kg/m²)。CT 示踪剂稀释曲线分析用于计算肾灌注,然后进行背景减除以定量评估肾功能。双能 MDCT 图像可进一步处理生成碘基和虚拟非增强数据集,计算肾/主动脉 CT 值和碘值比值作为肾功能的替代指标。
肥胖患者的皮下脂肪组织增加。虚拟非增强图显示肥胖患者的皮质和髓质基础衰减值降低。总体而言,基础衰减值与 BMI 呈负相关,与肾内脂肪沉积相一致。相反,经背景减除后的肾/主动脉 CT 值(after background subtraction)和肾/主动脉碘值比值在消瘦组和肥胖组之间无差异,且与 BMI 呈正相关。这些发现表明,在进行背景减除后,CT 值可靠地反映了基础组织衰减值。
因此,我们的研究结果支持我们的假说,即在 MDCT 检查中,尽管由于肾脂肪沉积导致基础衰减值降低,但背景减除技术仍可用于可靠评估轻度肥胖患者的肾功能。